Redcliffe Labs is taking on incumbents like Dr Lal PathLabs. But is it biting more than it can chew?

Redcliffe Labs is taking on incumbents like Dr Lal PathLabs. But is it biting more than it can chew?

Dheeraj Jain, founder and MD, Redcliffe Labs; image credit: Redcliffe Labs

Synopsis

Having set itself a target to reach INR5,000 crore in revenue by 2029, Redcliffe Labs is expanding rapidly and spending big on marketing. But scaling up in a services industry like diagnostics isn’t easy. Without sufficient funding, it may not be able to tap the small-town potential it is banking on. Besides, competition and pricing pressure are intense.

Diagnostics chain Redcliffe Labs has been making quite a buzz of late. It is gearing up to take on the incumbents and make a mark in the fragmented diagnostics market in India. Started in 2018 as a company focused genetic, specialised, and rare diseases testing, Redcliffe Labs ventured into infectious diseases, including Covid-19 testing in 2020 and expanded to a full-stack testing menu of routine and specialised pathology tests as well as

To Read the Full Story, Become an ET Prime Member

Access the exclusive Economic Times stories, Editorial and Expert opinion

Monsoon Offer

Get flat 20% off

on ETPrime membership

Membership Benefits

Access the exclusive Economic Times

Stories, Editorial & Expert opinion

Complete Access with ET Prime

Experience your Economic Times newspaper, The way you've always liked!

Get to know where the market gurus invest & grow your portfolio.

Stock Report Plus

In-depth stock analysis for 4000+ companies

Stock Analyzer

Instant stock analysis based on Solvency, Profitability, Growth, Valuation, Momentum, Risk & More.

Now Available with ET Prime

Manage your money efficiently with this weekly guide.

Clean experience

with minimal ads

Easy & distraction-free reading with 90% less ads

Sharp Insight-rich,

In-depth stories across 20+ sectors

1500+ Exclusive stories & analysis across sectors to help you stay informed

Get One Year Times Prime Subscription worth ₹1199 for free

Get 1 Year Complimentary Subscription of TOI+ worth Rs.799/-

Enjoy unlimited access to breaking news and thought provoking stories from all around the world.

Get One Year Docubay Subscription worth ₹999 for free

Stream award-winning international documentaries from more than 100 countries.

Offers By Our Partners

Exclusively for ET Prime Members

Members Love Us

The stalwarts of the industry trust ET Prime for insightful analysis & unbiased thought pieces

Gift a story

Your membership includes Story Gifting Credits. Now gift exclusive stories to your friends & peers.

Comment & Engage

with ET Prime community

Communicate & build a connection with great minds of the industry

A trusted team of

Journalists & Analysts

Unbiased perspective & detailed reporting by our team of journalists who have in-depth knowledge and years of experience